相关实验视频

Updated: Mar 14, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

基于网络药理学分析的Nujia蜂蜜化合物的对慢性不可预测轻度压力 (CUMS) 抑郁老鼠的影响和机制

Shaowei Fu¹, Mahinur Bakri², Xueying Lu²

¹The State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China; University of Chinese Academy of Sciences, Beijing 100039, China.

Journal of ethnopharmacology

|March 12, 2026

概括

在传统维吾尔医学中用于治疗抑郁症的努吉亚蜂蜜糊,通过减少神经炎症和亡而显示抗抑郁作用,同时增强突触可塑性. 这项研究澄清了其潜在治疗用途的多目标机制.

科学领域:

药理学药理学是指药理学的学科.
神经科学是一个神经科学.
传统医学的传统医学.

背景情况:

努吉亚蜂蜜糊是一种传统维吾尔医学配方,历史上用于治疗抑郁症.
它用于治疗抑郁症的药理动力学基础尚未完全理解.
了解Nujia的机制对于验证其有效性至关重要.

研究的目的:

系统地调查Nujia的抗抑郁药疗效和机制.
结合化学分析,计算预测和实验验证.
提供对Nujia治疗作用的全面了解.

主要方法:

LC/MS分析确定了Nujia的化学成分和血液吸收的化合物.
网络药理学和分子对接预测和验证了抗抑郁药物标.
用一个CUMS大鼠模型与行为测试,ELISA,组织病理学,西部斑块和qRT-PCR一起评估疗效和机制.

主要成果:

在Nujia.中,LC/MS确定了124种成分和26种血液吸收化合物.
在CUMS大鼠中,Nujia改善了类似抑郁症的行为和神经病理.
机制包括上调神经递质和神经变因子,下调促炎细胞因子,抑制TNF-α/NF-κB,激活PI3K/AKT,增强突触可塑性蛋白.

结论:

努吉亚通过多路径协同作用表现出抗抑郁作用.
关键途径包括TNF-α/NF-κB和PI3K/AKT信号传递.
努吉亚可以缓解神经炎症,减轻亡,增强突触可塑性.

关键词:

化学定型是指化学定型是指化学定型.化合物努吉亚蜂蜜糊混合物努吉亚蜂蜜糊抑郁症抑郁症抑郁症多目标机制多目标机制网络药理学网络药理学

更多相关视频

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Author Spotlight: Establishing a Rodent Model for Investigating Depression Factors in Traditional Mongolian Medicine

Published on: October 27, 2023

相关概念视频

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...